| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |